Document is current
Any future updates will be listed below
-
Authors
Aiello, Edoardo Nicolò
Solca, Federica
Torre, Silvia
Colombo, Eleonora
Maranzano, Alessio
Olivero, Marco
Scheveger, Francesco
Morelli, Claudia
Doretti, Alberto
Verde, Federico
Ferrucci, Roberta
Barbieri, Sergio
Mameli, Francesca
Priori, Alberto
Silani, Vincenzo
Ticozzi, Nicola
Poletti, Barbara https://orcid.org/0000-0003-4398-2051
- License Information
-
More Information
Article History
Received: 25 February 2023
Accepted: 31 March 2023
First Online: 5 April 2023
Declarations
:
: V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon, receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>, <i>European Neurology</i>, <i>American Journal of Neurodegenerative Diseases</i>, <i>Frontiers in Neurology</i> and <i>Exploration of Neuroprotective Therapy</i>. B.P. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l B.P is Associate Editor for <i>Frontiers in Neuroscience</i>. N. T. received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for <i>Frontiers in Aging Neuroscience</i>.
: The participants provided informed consent. This study was approved by the Ethics Committee of IRCCS Istituto Auxologico Italiano (I.D.: 2013_06_25).
